Invasive Urothelial Carcinoma: Subtypes and Divergent Differentiation
- PMID: 36343133
- Bookshelf ID: NBK585978
- DOI: 10.36255/exon-publications-urologic-cancers-urothelial-carcinoma
Invasive Urothelial Carcinoma: Subtypes and Divergent Differentiation
Excerpt
Invasive urothelial carcinoma is the most frequent type of bladder cancer and may occur in pure or classical form or with the presence of variant or subtype histology and/or evidence of divergent morphology such as squamous, glandular, or trophoblastic differentiation. Increasingly, it is recognized that certain subtypes impact patient prognosis and outcome hence the need to correctly recognize and document their presence. Certain subtypes and divergent features correlate with the emerging molecular bladder cancer subtypes, which can also influence patient management decisions. The pathologist therefore plays a crucial role in providing clinically relevant information, mostly derived from hematoxylin and eosin slides, which will guide urologists and oncologists in terms of risk stratification and treatment planning.
Copyright: The Authors.; The author confirms that the materials included in this chapter do not violate copyright laws. Where relevant, appropriate permissions have been obtained from the original copyright holder(s), and all original sources have been appropriately acknowledged or referenced.
Conflict of interest statement
Sections
- INTRODUCTION
- MICROPAPILLARY UROTHELIAL CARCINOMA
- PLASMACYTOID UROTHELIAL CARCINOMA
- NESTED UROTHELIAL CARCINOMA
- MICROCYSTIC UROTHELIAL CARCINOMA
- LYMPHOEPITHELIOMA-LIKE UROTHELIAL CARCINOMA
- CLEAR CELL (GLYCOGEN-RICH) UROTHELIAL CARCINOMA
- LIPID-RICH UROTHELIAL CARCINOMA
- GIANT CELL UROTHELIAL CARCINOMA
- UROTHELIAL CARCINOMA WITH SQUAMOUS DIFFERENTIATION
- UROTHELIAL CARCINOMA WITH GLANDULAR DIFFERENTIATION
- UROTHELIAL CARCINOMA WITH TROPHOBLASTIC DIFFERENTIATION
- UROTHELIAL CARCINOMA WITH SARCOMATOID DIFFERENTIATION
- UROTHELIAL CARCINOMA WITH NEUROENDOCRINE DIFFERENTIATION
- MOLECULAR CLASSIFICATION OF INVASIVE UROTHELIAL CARCINOMA
- CONCLUSION
- REFERENCES
References
-
- Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pineros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021 https://doi.org/10.1002/ijc.33588 . - DOI - PubMed
-
- Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7–33. https://doi.org/10.3322/caac.21654 . - DOI - PubMed
-
- Moch H, Humphrey PA, Ulbright TM, Reuter V. International Agency for Research on Cancer. 4th Edition ed. Lyon, France: Infiltrating Urothelial Carcinoma; 2016. WHO Classification of Tumours of the Urinary System and Male Genital Organs; pp. 81–98.
-
- Paner GP, Annaiah C, Gulmann C, Rao P, Ro JY, Hansel DE, et al. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder. Hum Pathol. 2014;45:1473–1482. https://doi.org/10.1016/j.humpath.2014.02.024 . - DOI - PubMed
-
- Sangoi AR, Beck AH, Amin MB, Cheng L, Epstein JI, Hansel DE, et al. Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol. 2010;34:1367–1376. https://doi.org/10.1097/PAS.0b013e3181ec86b3 . - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources